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5-HT serotonin (5-hydroxytryptamine) 
AC absolute control 
ACTH adrenocorticotrophic hormone 
AVP arginine-vasopressin 
CAT corynanthine 
cAMP cyclic adenosine monophosphate 
ClB chlorobenzene mixture 
DA dopamine 
E epinephrine 
EPM elevated plus maze 
GAL galanin 
HA histamine 
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NE norepinephrine 
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OF open-field 
OXT oxytocin 
PDL pindolol 
POP/EDCs persistent organic pollutants with endocrine disruptor effects 
PVN paraventricular nucleus 
RI resident-intruder 
RIA radioimmunoassay 
SC stress control 
SON supraoptic nucleus 
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1. INTRODUCTION 
The arginine-vasopressin (AVP)-ergic and oxytocin (OXT)-ergic systems are 
crucial in homeostatic maintenance, via the amounts of these mediators secreted into the 
bloodstream or extracellular/cerebrospinal fluid. Homeostasis is implemented by both 
physiological and behavioral patterns, and can be maintained inter alia via AVP- and 
OXT-mediated behavior, including anxiety and aggression. Anxiety enhances the 
capability and motivation to stress, while aggression helps gain better access to resources. 
Behavior results from the interactions (e.g. neuroendocrine) of homeostatic regulators and 
the underlying mechanisms. The AVP-ergic and OXT-ergic systems interact with central 
(neurogenic) and/or peripheral regulators; incidentally influenced by internal-external 
impacts, they are involved in a broad range of behavior, such as emotionality or social 
attachments, and various systematic functions. Accordingly, if the secretion of AVP 
and/or OXT in the relevant central areas is altered, behavioral and/or physiological 
abnormalities may appear.  
The coexistence and interactions between AVP-ergic and OXT-ergic and 
neurogenic systems related, for example the monoaminergic regulators dopamine (DA), 
serotonin (5-HT), histamine (HA), norepinephrine (NE), epinephrine (E) or the 
peptidergic galanin (GAL) systems, have been partially studied to date. However, the 
studies concerning these regulators with regard to AVP and OXT secretion have been 
performed practically only from the aspect of levels located within intra- or 
extrahypothalamic superior brain areas, and much less so at the level of the 
neurohypophysis (NH), which is a lower regulating area of hypothalamo-
neurohypophyseal AVP and OXT release. Besides their glial functions, pituicytes in the 
NH may also have roles in AVP and OXT expression. In an in vitro NH model, AVP and 
OXT were revealed to be secreted by radioimmunoassay (RIA) and mass spectrometry. 
Pituicytes are sensitive to osmotic changes, and the activation of AVP expression may 
also be due to the osmosensitivity of NH glial cells. The existence (receptors, mediators, 
innervations or the related functions) of the monoaminergic and peptidergic neurogens 
mentioned above (which have been proven to be involved in neuropeptide secretion at 
higher regulating levels in the brain) has been partially verified within the hypothalamo-
neurohypophyseal system under in vivo conditions. We concluded earlier that NH 
cultures could be used as a model to investigate basal (non-stimulated, intact) AVP and 
OXT secretion, and that stimulated by osmosis or certain neurogenic monoamines. Such 
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cultures can be used because of their ability to release (and synthesize) nonapeptides, and 
the presence of neurogenic regulators (e.g. monoaminergic receptors on the surface of 
pituicytes) found earlier in ”in vivo functional” superior brain structures. Its simplicity 
and low costs may enhance the usefulness of the model. We hypothetized that the 
involvements of DA, 5-HT or HA found earlier could be occur at the level of the NH in 
vivo independently of the hypothalamus. Our recent findings and related published data 
suggest that roles of the neurogens analogous to those observed in in vitro NH cultures 
exist at higher regulatory levels (”superior” neurons). These brain areas could mainly be 
affected in the evolution or background of AVP- and OXT-related behavioral forms, 
including anxiety and aggression, and/or in some of their known physiological functions.  
Ubiquitous external-environmental impacts can alter the neuroendocrine systems, 
both centrally and/or peripherally, and indeed abnormal behavior may occur. Some 
pollutants may also alter AVP- and OXT-mediated behavior. The available data indicate 
that such stressors may stimulate the secretion of various underlying hormones. The 
synchronous (central and peripheral) effects of these stressors may be explained by the 
presence of central and peripheral (target) neurogenic regulators (such as DA, 5-HT or 
HA) and the (environmental) impact features (such as the physico-chemical properties, 
the route of action, the duration and the dose). Many semi-volatile, bioaccumulative 
pollutants have the ability to interfere with central and/or peripheral endocrine elements 
(POP/EDCs). Because of the numerous possible endocrine targets in the central nervous 
system, POP/EDCs are capable of disturbing behavior directly, via action on hormones 
either alone or additively or synergistically in ambient mixtures. POP/EDCs are usually 
found in tissues and, especially in complex mixtures, such agents may be biologically 
active even at extremely low doses in vivo. Chlorobenzenes, and especially the 
hexachlorobenzene (HCB), are often applied as a model to study POP/EDCs though little 
information is available on the neurobehavioral effects of HCB or other chlorobenzenes 
on emotional or other AVP- and/or OXT-mediated behavior. HCB contamination causes 
not only neurotoxicological symptoms, but also neuropsychiatric signs such as an 
increased frequency of schizophrenia and hypochondria. The effects of long-term dietary 
exposure to HCB on aggressive behavior and regional brain biogenic mediators, including 
the concentrations of the neuropeptide-related (and the interacting) monoamines (e.g. NE 
and 5-HT), have already been examined. Following exposure, the subjects displayed 
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abnormal aggressiveness, and changes were also observed in the monoaminergic 
mediator concentrations in various superior brain areas. 
A topical question is an investigation of neurogenic involvement in AVP and OXT 
secretion under ”environmentally stimulated” conditions. A POP/EDC (e.g. HCB), or 
such agents in a mixture, may be used for stimulation.  
 
2. AIMS 
The involvement of monoaminergic regulators and interactions between 
monoamines and GAL in AVP and OXT release have been investigated, in part through 
use of an in vitro NH model. We set out to acquie a deeper understanding of neurogenic 
involvement, under both basal (aims 1 and 2) and environmentally stimulated conditions 
(aims 3 and 4).  
 Aim 1. To clarify the roles of NE and E in AVP and OXT secretion, using 
the NH model, and to identify the specific adrenoceptors involved on the 
pituicytes.  
 Aim 2. To reveal the interactions between GAL and the monoamine 
neurogens in the secretion of AVP and OXT, using the NH model.  
Certain environmental impacts (ubiquitous stressors), even at low doses, may alter 
behavior, including AVP- and OXT-dependent forms, affecting related neuroendocrine 
elements at the different regulating levels. This led to: 
 Aim 3. To examine the consequences of exposure to a POP/EDC mixture 
(orally applied chlorobenzene agents) on anxiety-related behavior and 
aggression, and on peripheral AVP and OXT secretion in vivo.  
 Aim 4. To examine whether the changes in AVP and OXT secretion can be 
interpreted with the NH model, and whether neurogenic involvement in 
AVP and OXT secretion is modified under environmentally stimulated 
conditions. 
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3. MATERIALS AND METHODS 
3.1 Animals, experimental groups and environmental impacts 
Male Wistar rats were used, maintained under controlled conditions, with food and 
water provided ad libitum. Subjects for aims 1 and 2 were not exposed, but those for aims 
3 and 4 were divided into experimental groups and exposed environmentally. Smaller, 
unrelated male rats, maintained separately, were used as intruders [section 3.3.3]. For the 
examinations in aims 1 and 2, no groups were created. For the examinations in aims 3 and 
4, subjects divided into groups were subjected to environmental exposure. Orally 
administratered 0.1 (D1) or 1 (D2) μg/kg/day 1:1 1,2,4-trichlorobenzene + HCB (ClB) 
was used. Rats were exposed to ClB for 30, 60 or 90 days (groups D1/D2-ClB-30/60/90) 
or to stomach tube insertion only (as stress controls, groups SC) for 30, 60 or 90 days (as 
groups SC-30/60/90) or were not exposed (absolute controls, group AC).  
3.2. Protocols 
3.2.1. Neurogenic involvement in AVP and OXT secretion in non-stimulated NH cultures 
Rats (for aims 1 and 2) were killed and NH cultures were prepared [section 3.4.1]. 
Confluent cultures were incubated [sections 3.4.2.1-2]. The supernatant was harvested 
and AVP and OXT levels were assayed [section 3.5.1]. 
3.2.2. Behavioral and endocrine effects of external-environmental impact, neurogenic 
involvement in AVP and OXT secretion in stimulated NH cultures 
Subjects (for aims 3 and 4) were exposed [section 3.1], the behavior related to 
anxiety, locomotion and exploration was observed in open-field (OF) and elevated plus 
maze (EPM) tests and the aggressive behavioral elements were evaluated with the neutral 
cage paradigm of the resident-intruder (RI) tests [section 3.3]. Following the tests, the rats 
were sacrified, and the plasma levels of AVP, OXT, adrenocorticotrophic hormone 
(ACTH) [sections 3.5.1-2] and toxicity markers [section 3.5.4] were determined. 
Hypophyses were dislodged and NH cultures were prepared [section 3.4.1]. Confluent 
cultures were incubated [section 3.4.2.3]. The AVP and OXT levels of the harvested 
supernatant were measured [section 3.5.1]. 
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3.3. Measurements of behavioral elements 
3.3.1. OF tests  
To determine anxiety-related behavior, locomotion and exploration, OF tests were 
performed. The following behavioral elements were observed: the percentages of time 
spent in the centre and the periphery, the total distance moved, the mean velocity, and the 
total duration and numbers of rearing, grooming, sniffing, freezing and defecation 
episodes.  
3.3.2. EPM tests  
EPM tests were performed to determine anxiety-related behavior. The following 
behavioral elements were measured: the total duration in all open or closed arms, the 
preferred site of the apparatus, the numbers of entries into the various zones, the number 
of head-dipping episodes, and the total duration and numbers of rearing, grooming, 
sniffing and freezing episodes. 
3.3.3. RI tests  
RI tests were applied to determine intermale aggressive behavior. The resident was 
placed in the arena for area habituation, and was left to explore it. The parameters relating 
to the locomotion, exploration and self-care as measured in the OF tests were recorded 
throughout the habituation and later, until the end of the test. After habituation, an 
intruder was introduced to the resident. The offensive (the total duration and numbers of 
aggressive grooming episodes, lateral threats, menacing postures, chasing and biting 
attacks), defensive (the total duration and numbers of defensive upright posture and 
immobility episodes). and social (naso-nasal and naso-genital contacts) elements of the 
resident were recorded.  
 
3.4. Cell culture techniques 
3.4.1. Preparation of NH cultures 
Primary NH culturing was performed. Cultured cells were kept in a humidified 
atmosphere of 5% CO2 in air at 37 °C.  
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3.4.2. Incubation procedures with neurogen mediators 
Conditions, methods, dose/time effects, kinetic curves and relations between DA, 5-
HT, HA, GAL and AVP and OXT secretion were in part as described earlier. For 
incubation procedures, only confluent monolayers were used, because the basal AVP and 
OXT contents of the supernatant had become constant. Functionality was checked, and 
the medium was changed and then left untouched before manipulations. 
3.4.2.1. Adrenergic involvement in NH cultures (aim 1) 
For the study of NE/E involvement in the AVP and OXT secretion of non-
stimulated, intact NH cultures, receptor-specific mediators (such as adrenoreceptor 
agonists; α- and β-antagonists) were used. The dose-time kinetic characterization was 
designed and performed as applied earlier in the cases of DA, 5-HT or HA.  
3.4.2.2. GAL-monoamine interactions in NH cultures (aim 2) 
For examination of the interactions between the monoaminergic agonist mediators 
and GAL, incubation procedures were performed (in all possible variations) on NH 
cultures. Doses and times were chosen on the basis of (partially published) kinetic 
examinations. 
3.4.2.3. Neurogenic involvement in NH cultures prepared from ClB-exposed (stimulated) 
rats (aims 3 and 4) 
NH cultures prepared from rats (AC or exposed for 30, 60 or 90 days) were 
incubated with either medium vehicle only or 10
-6
 M 5-HT or 10
-6
 M NE. The choice of 
5-HT and NE was based on their importance in the evolution of AVP/OXT-related 
behavior. After manipulation, the supernatant was collected and stored at -70 °C until 
RIA assay. 
3.5. Measurements and assays 
3.5.1. Determination of AVP and OXT secretion of NH cultures and plasma AVP and 
OXT levels 
Sample collection and the conditions for measurement of the supernatant AVP and 
OXT levels from NH cultures were as described earlier. Measurements were based on 
modified RIA methods for AVP and OXT detection. The sensitivity of the assays for 
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AVP and OXT was 1 pg/tube. Following extraction with a recovery of ≥95%, the plasma 
AVP and OXT levels were assayed by the same RIA method.  
3.5.2. Determination of plasma ACTH 
Plasma ACTH levels were measured by an immunochemiluminescence assay with 
an Immulite 2000 apparatus, using DPC kits.  
3.5.3. Determination of total protein concentration 
Total protein concentration was measured by spectrophotometry with a modified 
Lowry method and/or using a commercial kit. 
3.5.4. Determination of toxic characteristics of exposure to the POP/EDC impact 
Toxicity marker liver transferases were measured by standard kinetic methods. The 
subjects were weighed throughout, and the brain and main organs were removed and 
weighed. Signs indicative of HCB or 1,2,4-trichlorobenzene toxicity were monitored, and 
general morphological examinations were performed with conventional stains on the 
specimens prepared from excised organs. 
3.6. Statistical analysis 
Data for aims 1 and 2 were analyzed with the Kruskal–Wallis test. Data for aims 3 
and 4 were processed by factorial analysis of the variance. The factors were: treatment 
(/AC/, ClB or SC) and duration of treatment (30, 60 or 90 days). Groups were compared 
by using Fisher’s LSD post hoc test and the Dunnett post hoc test. Changes were 
considered statistically significant at p<0.05.  
 
4. RESULTS AND DISCUSSION 
Aim 1. We found that pretreatment with corynanthine (CAT, as an α1-receptor 
antagonist) or phentolamine (as an α1+α2-receptor antagonist) effectively inhibited the E-
stimulated AVP and OXT release of NH cultures. After pretreatment with E, these 
antagonists did not block the increasing effects of E. The α2- (and slightly α1)-receptor 
antagonist yohimbine was ineffective before treatment with E for both AVP and OXT. 
Pretreatment with CAT before treatment with NE reduced the NE-stimulated AVP release 
(for OXT, data are not yet available) because NE has an α1-receptor agonist character 
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besides its β-receptor agonist profile. However while the elevation of AVP secretion was 
totally blocked by pretreatment with CAT before treatment with E, CAT administratered 
before treatment with NE exerted only a partial blocking effect. Pretreatment with 
propanolol (a β1+ β2 -receptor antagonist) was sufficiently effective for both AVP and 
OXT, but pretreatment with atenolol (a β1-receptor antagonist) did not prevent either NE-
stimulated AVP or OXT secretion. It was surprising that pretreatment with pindolol 
(PDL, a β1+ β2-receptor antagonist) alone (or both pretreatment with PDL and treatment 
with NE) significantly increased NE-stimulated AVP secretion. This apparetly 
contradictory effect can be explained in that PDL not only acts as a blocker, but also 
exerts intrinsic sympathomimetic action and a strong adrenergic agonist effect. The 
molecular mechanisms of the intrinsic sympathomimetic action of PDL have not been 
clarified. It was hypothesized that the receptor loss induced by β-antagonists with 
intrinsic sympathomimetic action is mediated through cyclic adenosine monophosphate 
(cAMP). PDL stimulated cAMP accumulation 100-fold over the basal rate, and the 
increase in cAMP formation is the rate-limiting step for the biological response of partial 
agonists. We conclude that mainly α1-receptors may be involved in E-stimulated AVP 
and OXT secretion, and β2-receptors in NE-stimulated AVP and OXT secretion in vitro.  
Aim 2. Our present and eariler findings indicate that AVP and OXT secretion can 
be influenced directly by the GAL-ergic system, and that GAL-ergic control of the AVP 
and OXT secretion in rats occurs independently of the hypothalamus, at the level of the 
NH. Our results permit the supposition that GAL receptors do exist on pituicytes cultured 
in vitro. We presume that the effects of GAL–monoamine interactions on AVP and OXT 
secretion can develop through the monoaminergic receptors in the NH. This hypothesis is 
supported by the present findings, i.e. GAL had no effect on the increases induced in the 
levels of AVP and OXT by K
+
 administration, which causes nonspecific, receptor-
independent hormone secretion. We have demonstrated that the administration of GAL 
before E or NE prevents the enhancement of AVP and OXT secretion. Before 5-HT or 
HA administration, GAL has a moderate decreasing effect. The changes induced in AVP 
and OXT secretion by the monoaminergic system can be directly influenced by the GAL-
ergic system.  
Aims 3 and 4. POP/EDCs, including chlorobenzenes, can cross the blood-brain 
barrier and accumulate. They can reach a critical dosage and induce cellular mechanisms 
which may disturb the endocrine elements/functions, including behavior-related hormonal 
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mechanisms. The measured parameters in the AC and SC animals did not differed 
significantly. It may therefore be conclude of that the observed consequences did not 
originate from the (neuro)toxicity of the applied exposure and/or the stressing effects of 
handling or the oral gavage. 
Aggression and anxiety-related behavior are appreciably affected by AVP and 
OXT. AVP has anxiogenic effects and OXT has anxiolytic effects, while AVP increases 
intermale aggression and OXT is involved particularly in maternal care and aggression. 
Regulation of the neuropeptides is implemented by many factors, including the 
neurogenic 5-HT- or NE-related elements. Their effects are involved in AVP and OXT 
regulation in higher brain levels e.g. in the hypothalamic paraventricular nucleus (PVN) 
and the supraoptic nucleus (SON). It has been reported that NE increases both AVP and 
OXT expression in the PVN and SON, and 5-HT is postulated to stimulate both AVP and 
OXT expression in the PVN, but only OXT in the SON. Other papers have identified the 
involvement of 5-HT receptors in different areas related to AVP or OXT production or 
secretion. NE can increase the central and peripheral release of neuropeptides, mainly via 
the involvement of HA-ergic neurons. Nevertheless, NE has also been reported to inhibit 
AVP release. Correlative roles of AVP and 5-HT and/or NE in various aspects of 
emotional or social behavior or the related disorders too have been described. 
Incubation procedures were performed to examine monoamine-mediated AVP and 
OXT secretion and the changes under stimulated conditions caused by exposure to ClB. 
Even the basal levels of secreted AVP and OXT were altered. In the NH cultures prepared 
from ClB-exposed rats, elevated neuropeptide secretion was found, depending on the 
duration of exposure. Moreover, ClB for 90 days resulted in significant elevations of the 
secreted AVP and OXT levels. Our published data indicated that 5-HT or NE as specific 
monoaminergic receptor agonists, significantly increased the secretion of both AVP and 
OXT from NH cultures prepared from unexposed animals. Such stimulation can be 
inhibited with specific antagonists, and the receptors acting in the NH cultures were 
therefore clarified in detail by our group. In NH cultures prepared from exposed rats, 
neuropeptide secretion was also induced following 5-HT or NE incubation, but the 
increase was higher. We suspect that the basal and monoamine-mediated secretion of 
AVP and OXT was affected environmentally. ClB administrated chronically by stomach 
tube may pass into the behavior-related brain areas and concurrently the hypothalamo-
neurohypophyseal system, including the pituicytes of the posterior pituitary. In cells, 
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HCB may modulate gene expression and induce various process. We suspect that changes 
observed in vitro in the basal and monoamine-mediated secretion (with the environmental 
influences) could appear at various levels of neuropeptide secretion simultaneously.  
After exposure, plasma AVP and OXT levels were measured as results of peripheral 
(hypothalamo-neurohypophyseal) neuropeptide secretion. Exposure for 30 or 60 days did 
not change the AVP levels considerably, whereas ClB for 60 days enhanced the OXT 
level, and ClB for 90 days elevated the levels of both AVP and OXT in the plasma. Our 
findings may result from modulated peripheral secretion caused by alterations of similar 
regulations due to HCB mechanisms acting on the SON and/or the PVN or in the NH. 
Our results may correlate with the findings of increased plasma and/or cerebrospinal AVP 
levels in patients with anxiety disorders. Various anxiety disorders are associated with 
elevated AVP concentrations e.g. an increased plasma AVP level was measured in 
patients with post-traumatic stress disorder or obsessive–compulsive disorder. Our study 
revealed that the SC groups did not exhibit increases in OXT (or AVP) levels, though the 
stress caused by ClB may have induced peripheral OXT release. Few data are available 
concerning a correlation between the plasma AVP (or OXT) and aggressive behavior. 
Instead of neuropeptides, mainly the plasma levels of 5-HT, testosterone or 
glucocorticoids are mentioned as correlating with regulatory amounts of aggressive 
behavior. However, in the cerebrospinal fluid the AVP (and OXT or other regulators) 
concentration seemed to correlate, usually dose-dependently with the relevant aggression. 
The plasma ACTH levels were elevated directly proportionally to features of the 
exposure. Increasing ACTH levels may be related to parvicellular AVP-related elements 
affected by exposures. AVP and corticotropin releasing hormone released into the portal 
circulation at the median eminence, or even the AVP released into the short portal vessels 
within the NH, are known to stimulate ACTH secretion in the adenohypophysis, which 
triggers the adrenal release of glucocorticoids and facilitates physiological and behavioral 
adaptation to stressors.  
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5. CONCLUSIONS 
NE and E increased AVP and OXT secretion in NH cultures in vitro. The α1-
receptors are probably involved in E-stimulated AVP and OXT secretion, the β2-receptors 
are probably involved in NE-stimulated AVP and OXT secretion. 
GAL interacts with monoamine neurogens, decreasing or inhibiting their effects 
increasing AVP and OXT secretion.  
Our findings may relate to disturbances in AVP and OXT secretion at different 
regulatory levels. Chlorobenzenes act as discrete anxiogenous factors and have the 
potential to influence behavioral elements of aggression. These pollutants may pose 
potential risks in the etiology of psychiatric disorders with symptoms of abnormal anxiety 
and/or aggressiveness. 
Besides the suggested changes in superior AVP- and OXT-related brain areas, the 
basal secretion of AVP and OXT in NH cultures prepared from exposed animals was also 
influenced to extents depending on the duration of exposure. The 5-HT-, and NE-
stimulated neuropeptide secretion in our NH model seemed to be disturbed following the 
external impact. Various features of the exposure, and mainly the presence of similar 
neurogenic regulators in behavior-related brain areas, suggest that the changes observed 
in the NH model may be interpreted as possible, underlying mechanisms of the behavioral 
phenomena exhibited. 
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